Investors/Media

Investors / Media

Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways.

Stock Chart

More »
Stock chart for: INFI.O.  Currently trading at $1.70 with a 52 week high of $3.84 and a 52 week low of $0.84.

Recent Events

View all events »
Infinity Pharmaceuticals, Inc. at Precision Lung Cancer Conference
Jul 25, 2017 10:00 a.m. ET
Infinity Pharmaceuticals, Inc. at 2017 Biotechnology Innovation Organization (BIO) International Convention
Jun 22, 2017 1:00 p.m. PT
Infinity Pharmaceuticals, Inc. at JMP Securities Annual Life Sciences Conference
Jun 21, 2017 10:00 a.m. ET

Recent Releases

More >>
Infinity to Participate in Three Upcoming Conferences
Jun 14, 2017
CAMBRIDGE, Mass., June 14, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI), a clinical-stage biotechnology company developing IPI-549, a potentially first-in-class immuno-oncology product candidate that selectively inhibits phosphoinositide-3-kinase gamma (PI3K-gamma), today announced that management will be participating in the following three upcoming conferences: JMP Securities Annual Life Sciences Conference: Infinity will participate in the JMP Securities Annual Life... 
Infinity Provides Company Update and Reports First Quarter 2017 Financial Results
May 09, 2017
- Patient Enrollment Ongoing in IPI-549 Dose-Escalation in Phase 1 Clinical Study - - Phase 1 Monotherapy and Combination Expansions Expected to Initiate in the Second Half of 2017 - - Additional Phase 1 Data Anticipated in the Second Half of 2017 - CAMBRIDGE, Mass., May 9, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2017 financial results and provided an update on the company, including its progress with IPI-549, a potentially ... 
Infinity Announces the Date of Its First Quarter 2017 Financial Results Conference Call and Webcast
Apr 26, 2017
CAMBRIDGE, Mass., April 26, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Tuesday, May 9, 2017, at 4:30 p.m. ET to review its first quarter 2017 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at www.infi.com. To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five min... 
 

INFI (Common Stock)

Price:$1.70
Change:0.00 (0.00%)
Intraday High:$1.83
Intraday Low:$1.70
Volume:0
Jun 27, 2017 at 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Annual Report

2016 Annual Report
Data Provided by Thomson Reuters